Since the available data do not prove convincingly that elevated CRP, if observed soon after the onset of bleeding and in the absence of infection, is also predictive of a poor outcome among patients with primary ICH, we set out to test the hypothesis that elevated CRP on admission is associated with the severity of primary ICH and thereby predict an unfavorable outcome.
Methods
The protocol was approved by the ethics committee of the Northern Ostrobothnia Hospital District.
Patient Population
We conducted a survey, identifying all patients among the population of Northern Ostrobothnia, Finland, who were treated for primary ICH at Oulu University Hospital from January 1, 1993, to December 31, 2008. The hospital is the only one serving acute stroke patients in this area (population of 356,026 in 1993 and 389,671 in 2008). We excluded patients not living in the hospital's catchment area and those who had a brain tumor, aneurysm, vascular malformation, hematological malignancy, hemophilia, or head trauma. Six patients died before reaching the hospital, the diagnoses for whom were confirmed by autopsy. Altogether, 961 patients with first-ever primary ICH were identified. We then excluded patients whose CRP values were obtained more than 24 hours after the onset of the stroke, leaving a series of 813 patients with CRP values taken within 24 hours of ictus. The series included 114 patients who underwent surgery. The CRP values of 6 of these patients were obtained only after the operation (but still within 24 hours of ictus); these patients were also excluded. Thus, a total of 807 patients (84%) were included in the final analysis.
Neuroradiological Methods
Primary ICH was verified with a CT scan on admission by experienced neuroradiologists. The locations and volumes of primary ICHs were determined, and the presence of intraventricular hemorrhage was recorded. As in our previous work, 11 measurement of ICH volumes was performed as either with a sum of individual slice volumes 2 or with an easier ABC/2 method. 14 Presence of intraventricular hemorrhage (IVH) was dichotomized (yes/ no). If aneurysms or arteriovenous malformations were suspected as a cause for the hemorrhage, CT, MR, or digital subtraction angiography was performed immediately. Survivors were checked for other structural abnormalities by performing follow-up imaging (CT or MRI) 2-3 months after the hemorrhage.
Clinical Data
The patient's clinical condition on admission at the emergency department was assessed in terms of the Glasgow Coma Scale (GCS) score. 18 Scores were missing in 7 cases. Information on previous diseases, blood pressure history, and the use of anticoagulants and other medications was extracted from the hospital records. The patients were considered to be hypertensive if their blood pressure readings preceding the index stroke had repeatedly exceeded 160/90 mm Hg, in accordance with the WHO/ISH (World Health Organization/International Society of Hypertension) statement, 22 or if they were taking antihypertensive medication. Patients were recorded as having diabetes mellitus if they were taking oral hypoglycemic agents or insulin. Cardiac disease included myocardial infarction, coronary artery disease, heart failure, and/or atrial fibrillation. Blood samples for CRP analysis were obtained in the emergency department or on the ward the next morning. C-reactive protein values were recorded on a daily basis, and CRP was analyzed using a turbidimetric method (normal values < 10 mg/L, coefficient of variation < 6%; Siemens Activa).
Outcome Measurements
Death records were obtained from the Causes of Death Register and were checked for the entire patient series. Patients were followed up for 3 months at our outpatient clinic or on the hospital's rehabilitation ward, with the exception of some who showed exceptionally good recovery on discharge and were assumed to have maintained this state for at least 3 months unless they were readmitted. All patients who experienced deterioration or rebleeding were readmitted to our hospital. The outcome was assessed according to the Glasgow Outcome Scale (GOS); 12 patients with a score of 5 (good recovery) were considered to have a favorable outcome, whereas patients with scores of 1-4 (death, persistent vegetative state, or severe or moderate disability) were considered to have an unfavorable outcome.
Management
Immediately after admission the physician on duty chose the most appropriate treatment for the patient according to the hospital's treatment protocols at that time. Standard care, reversal of the warfarin effect, and thromboprophylaxis were performed according to institutional protocols. Hematomas were evacuated by standard craniotomy or through a bur hole in 114 cases.
Statistical Analysis
Data were analyzed using IBM SPSS Statistics for Windows (version 20.0, IBM Corp.). Categorical variables were compared by conventional statistical methods including Pearson's chi-square test and Fisher's exact test, and continuous variables were compared by t-tests, the Mann-Whitney U-test, a 1-way ANOVA, and/or the Kruskal-Wallis test for nonparametric ANOVA. Univariate associations between continuous variables were tested using Spearman rank correlation coefficients (r s ). Predictors of an unfavorable outcome 3 months after primary ICH were searched for using unconditional logistic regression. Maximum-likelihood forward elimination procedures were used, with the variables selected on the basis of their probability values (p < 0.05). The following variables were tested: sex, age, presence of cardiac disease, presence of diabetes mellitus, hematoma size (per ml), GCS score (per unit), IVH, subcortical hematoma location, hematoma evacuation, use of warfarin, and CRP level (per 10 mg/L) on admission. All significant predictors found in stepwise logistic regression were included in the final model. A 2-tailed p value < 0.05 was considered statistically significant.
Results
The baseline and clinical characteristics of the patients according to outcome are shown in Table 1 . One hundred ninety-two patients (24%) had a favorable outcome and 615 (76%) had an unfavorable outcome within 3 months. The patients with unfavorable outcome were significantly more often women and older than those with a favorable outcome. These patients also significantly more often had diabetes mellitus, cardiac disease, warfarin medication, a higher CRP value on admission, a lower GCS score, a larger hematoma, intraventricular bleeding, an evacuated hematoma, and infectious complications (Table 1) . Infectious complications were observed in 216 patients and included urinary tract infections in 8 (4%) of 192 patients with a favorable outcome and 80 (13%) of 615 patients with an unfavorable outcome (p < 0.001) and pneumonia in 3 (2%) of 192 patients with a favorable outcome and 125 (20%) of 615 patients with an unfavorable outcome (p < 0.001).
C-reactive protein values on admission were analyzed according to characteristics and outcome (Table  2 ). Due to the skewed distributions of the CRP values, nonparametric statistical methods were used. C-reactive protein values on admission were significantly higher in patients with cardiac disease, diabetes mellitus, warfarin treatment, and impaired outcome at 3 months. There was a threshold in CRP values between good recovery and unfavorable outcome. The size of the hematoma correlated with admission CRP levels (r s = 0.084, p = 0.018), but admission GCS score correlated significantly with CRP levels only more than 24 hours after primary ICH (at admission: r s = 0.067, p = 0.060; after 24 hours: r s = 0.237, p < 0.001). Admission CRP levels did not differ clearly in terms of later diagnoses of infections, but later CRP levels did show such a pattern (data not shown, p < 0.01).
The predictors of an unfavorable outcome are shown in Table 3 . In multivariable analysis the significant predictors of an unfavorable outcome were older age, diabetes mellitus, a low GCS score on admission, a large hematoma, the presence of intraventricular bleeding, nonsubcortical location, and elevated CRP value on admission. The risk of an unfavorable outcome increased 1.4-fold in the multivariable analysis for every 10-mg/L increase in CRP on admission (Table 3) .
The patients who developed pneumonia later (n = 128) had very high CRP values after ictus relative to those without pneumonia (47.9 ± 68.0 vs 21.5 ± 35.8 within 48 hours and 67.3 ± 59.1 vs 25.5 ± 42.5 within 96 hours, p < 0.001 for both). We then excluded the patients with pneumonia and repeated multivariable analysis for an unfavorable/favorable outcome, but the results were unchanged: high CRP on admission still predicted an unfavorable outcome (OR 1.45 per 10 mg/L [95% CI 1.10-1.90], p < 0.01).
Discussion
Our results demonstrate that an elevated CRP value, if observed on admission within 24 hours after ictus, independent of confounding factors predicts an unfavorable outcome following primary ICH. The effect of elevated CRP on admission cannot be explained by preexisting heart disease, diabetes mellitus, and severity of the bleeding or infections. The mechanisms behind hemorrhage-induced brain damage and the development of perihematomal edema are not clear, but inflammation is believed to be one important factor involved in the process. 1, 21 Castillo et al. hypothesized that certain regulatory pathways activated after primary ICH can prevent secondary brain damage in cases of small hematomas but can produce the opposite effect when larger hematomas are concerned. 5 In addition, high levels of CRP were found around the hemorrhagic clot in patients with large hematomas who died within 48 hours of primary ICH. 8 C-reactive protein, mainly produced in the hepatocytes in response to cytokines, is a sensitive nonspecific marker of inflammation and infection. Mildly elevated levels have been found in patients with hypertension, diabetes, heart disease, and smoking. 10 Hypertension and diabetes are also important risk factors for primary ICH. 3, 17 In our series cardiac disease and diabetes mellitus, but not hypertension, were significantly associated with elevated CRP. Cardiac disease and diabetes have also been found as predictors of death after ICH. 19, 20 In the present multivariable analysis, however, cardiac disease was not a predictor of an unfavorable outcome, suggesting that primary ICH itself influences CRP more than does cardiac disease.
A slightly elevated CRP level on admission was found in many of the patients who later developed pneumonia. These patients showed a poor clinical condition soon after the onset of stroke. Aspiration leads to pneumonia, and it may be aspiration that could explain the high CRP on admission. However, CRP can increase up to 1000-fold within a few hours after the onset of other inflammatory stimuli such as tissue necrosis and trauma. 16 The response reaches a peak at 48 hours after the initial stimulus and falls to baseline levels within 7-12 days once the inflammatory stimulus is over. 16 In our series the predictive value of elevated CRP for an unfavorable outcome persisted even after exclusion of the patients who later developed pneumonia, implying that aspiration and subsequent clinical pneumonia did not explain the association between elevated CRP on admission and an unfavorable outcome. We assume that the severity of the brain trauma is independently associated with high CRP on admission and thereby also with a poor outcome. This cannot be confirmed in our series, however, and the reason for the independent role of CRP on admission in predicting a poor outcome remains to be elucidated.
Serial CRP measurements taken on consecutive days could predict the outcome after primary ICH better than a single CRP taken at admission. 13 This was evident in our series, where not only the patients who already had elevated CRP on admission but also those who had an appreciable increase in CRP within 3 days had an unfavorable outcome. Such an increase in CRP after admission was frequently associated with pneumonia. Patients who are in a The strengths of this study lie in the strict inclusion criteria, the relatively large, homogeneous patient series, and the population-based design. The radiological analyses were performed carefully, and those responsible were blinded to the case histories. We were also able to take into account all of the well-known potential risk factors for the outcome following primary ICH and adjust for them in the analyses. One limitation was that we had to exclude 16% of the original patients because of a lack of admission CRP data. These patients who were excluded had the same mean hematoma size as those enrolled in the study, so we believe that this did not cause any notable selection bias. Another limitation was the retrospective, observational study design. Our patient population was nevertheless large enough to obtain the necessary statistical power to show a significant independent association between CRP levels on admission and the outcome following primary ICH. The result did not change even after excluding the patients who later developed pneumonia. Even so, some patients with a poor outcome may have had unnoticed aspirations on admission to the hospital that increased the admission CRP value.
Conclusions
An elevated CRP level on admission is an independent risk factor for an unfavorable outcome among patients with ICH and cannot be explained by preexisting heart disease, diabetes, or infections and severity of bleeding. Elevated CRP on admission can be a sign of unnoticed aspiration among patients with a poor clinical condition on admission, or in the absence of aspiration, it may suggest the presence of a severe brain trauma. 
